Biological Material Analysis TRIZ Cases

Optimized humanized TIGIT antibodies achieve high binding affinity and specificity while reducing immunogenicity for clinical tumor treatment applications.

An optical detection device measures enriched target cells via fluorescence, eliminating manual counting and reducing sample volume requirements.

Bright-field and fluorescent nanoparticle staining enable precise biological substance detection in tissue sections.

Housekeeping proteins provide in-situ calibration references that eliminate human error and sample preparation variability during biomarker detection.

Segmenting total procalcitonin into stable fragments and native 1-116 forms resolves the trade-off between detection speed and clinical accuracy.

Gold nanoparticles immobilize STAT3 protein to detect activity shifts without labels, bypassing complex purification steps.

Hydrogel microparticles template water-in-oil emulsions to concentrate catalytic reporter signals within discrete microreactors.

A peptide exchange system modifies binding affinity to generate stable MHC class I tetramers with high precision.

Applying an ultrathin molecular imprinted polymer layer to the gate electrode reduces measurement stabilization time while maintaining detection specificity.

Segmented VHH domains target canine PD-1, improving treatment effectiveness while reducing adverse events in cancer therapy.

A dual acceptor BRET biosensor combines monomeric mNeonGreen and red fluorescent proteins to detect enzymatic activity.

Beta/MPZΔ engineered cells eliminate endogenous beta subunit interference to enable precise gating property analysis of voltage-gated sodium channels.

A beef-specific age determination marker uses p21 protein levels in muscle tissue to identify cattle age through antigen-antibody binding reactions.

Standardized laboratory method evaluates malaria diagnostic kits using controlled parasitemia levels to verify test performance.

Multi-parameter screening identifies SEMA4D antibodies that effectively inhibit tumor growth when combined with PD-1 checkpoint inhibitors.

An electrochemical sensor uses reduced graphene oxide, PEDOT:PSS, and Nafion to detect neurotransmitters.

A cancer analysis system calculates nematode chemotaxis indices using image processing and luminance variations.

Novel Rhacostoma green fluorescent protein peptides exhibit red-shifted excitation and emission spectra with improved quantum yield.

Specific antibody binds human c-MAF to detect genetic abnormalities, enabling prediction of bone metastasis in breast and lung cancers.

A fluid distributor pad uses hydrophobic barriers to route sample deposition across multiple lateral flow assays.

Truncated peptides bind influenza hemagglutinin to inhibit viral fusion, resolving the trade-off between molecular weight and binding specificity.

Collaborative enzyme enhanced reactive immunoassay detects PI3K pathway activation states to resolve prediction accuracy limits of single mutation biomarkers.

Segmenting isolation stages with specific surface markers identifies post-natal hemogenic endothelial cells, resolving detection limits in adult mammals.

Recombinant antibody 14G12-5 binds DR-70 with high affinity, resolving the lack of specific monoclonal antibodies for early cancer screening.

A polymer replica substrate preserves target molecule surface information for molecular imprinting.

Quantifies AMACR biomarkers in semen to diagnose prostate cancer with higher specificity than PSA tests, reducing reliance on invasive biopsies.

A protein marker panel combined with tSNE algorithms detects minimal residual disease in acute myeloid leukemia, resolving low sensitivity issues.

Serotype-specific antibodies resolve detection accuracy versus time consumption trade-offs by enabling rapid, precise identification of dengue serotypes.

Segmenting and merging variable regions creates a stable scFv format that maintains high BCMA binding specificity while reducing molecular weight.

Chromogranin A biomarker quantifies tumor burden to resolve understaging contradictions and guide therapy control.

Anti-Ly6E antibodies bind specifically to Ly6E proteins for precise detection and targeted treatment applications.

QuasAr6 indicators resolve optical crosstalk by shifting emission to 600-680 nm for simultaneous all-optical electrophysiology.

A humanized integrin alpha10 antibody inhibits cancer cell adhesion and migration.

RAFT polymerization creates molecularly imprinted particles with crosslinked cores and detectable labels for analyte capture.

Single-chain Fv antibodies detect multiple filovirus species via conserved epitopes, resolving limited broad-spectrum diagnostic effectiveness.

Magnetic bead separation isolates low-abundance lipid vesicles, boosting signal-to-noise ratio against background noise during detection.

Fluorescent markers identify microvesicles in whole blood, avoiding centrifugation artifacts and improving reproducibility.

Plasma phospholipid ratios enable accurate cancer diagnosis without complex sample preconditioning steps required by proteomics.

A binding peptide masks surface antigens on blood cell membranes to isolate target antibody signals.

A cytokeratin 8/18 complex-specific autoantibody enables non-invasive breast cancer detection through serum analysis.

Periodic nanopost arrays enhance radial diffusion and sensitivity while reducing sample volume requirements compared to planar biosensors.

Extended incubation with labeled antibodies overcomes antigen masking to achieve accurate epithelial cell quantification in blood samples.

Optimized variable regions in 2DD8-derived antibodies achieve selective binding to SARS-CoV-2 while minimizing cross-reactivity with other coronaviruses.

Fluorescent dopamine analogs label dopaminergic neurons to identify therapeutic agents, bypassing time-consuming mammalian animal models.

Evaporative edge lithography forms lipid multilayer microarrays for local drug delivery to cells.

A urinary biomarker panel diagnoses prostate cancer using zinc, PSA, and spermine ratios normalized by creatinine levels.

A Treg isolation method uses CD4, CD25, CD127, and CD226 expression levels to identify pure regulatory cells.

A preloaded light-impermeable testing apparatus containing optical property-modifying additives.

Engineered SH3 domains minimize immunogenicity while maintaining stability, enabling intracellular therapeutic applications.